Guardant Health
GH
#2648
Rank
โ‚ฌ4.60 B
Marketcap
37,28ย โ‚ฌ
Share price
-5.71%
Change (1 day)
114.93%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚ฌ1.22 Billion

According to Guardant Health 's latest financial reports the company's total debt is โ‚ฌ1.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ1.28 B4.84%
2023-12-31โ‚ฌ1.22 B-4.07%
2022-12-31โ‚ฌ1.27 B5.24%
2021-12-31โ‚ฌ1.21 B74.61%
2020-12-31โ‚ฌ0.69 B1826.52%
2019-12-31โ‚ฌ36.06 M
2018-12-31N/A-100%
2017-12-31โ‚ฌ0.54 M-96.61%
2016-12-31โ‚ฌ16.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ0.17 B-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.81 B-33.20%๐Ÿ‡บ๐Ÿ‡ธ USA